In the life sciences sector, intellectual property is the core asset that defines a company’s value and attractiveness to investors. Mistakes made at an early stage can lead to the loss of rights to key technology or make commercialization impossible. This is why NIVIRON takes full responsibility for identifying, protecting, and strategically managing IP, integrating it seamlessly into the overall lifecycle of developing new treatment technologies.

We ensure IP control starting from the research phase, so that by the time the company is ready to enter the market, it has a solid and legally clean patent foundation that meets the requirements of investors, partners, and regulators.

Within this scope, we:

• Identify and classify intellectual property assets, including new treatment methods, drug formulations, delivery platforms, and related technologies;
• Conduct patent searches and analysis, including freedom-to-operate (FTO) assessments and patent landscape evaluations;
• Develop patent strategies aligned with jurisdictional requirements, regulatory demands, and market potential;
• Prepare and file patent applications, collaborating with specialized patent law firms in the US, EU, and other key regions;
• Manage the patent portfolio: maintenance, renewals, and scope expansion;
• Ensure rights enforcement and respond to infringements, including pre-litigation and litigation actions.

Outcome: we create a strong protective framework for the company’s technologies, ensuring a competitive edge and a secure path to market entry.